The Impact of Antibiotic Therapy Options and Multidisciplinary Approach in Prosthetic Joint Infections
Microorganisms · 24.09.2025 · 13 (10) · 2241
DOI: 10.3390/microorganisms13102241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 24.09.2025. Verfasst von João Lucas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic and Traumatology Department, ULS do Alto Ave, 4835-044 Guimarães, Portugal. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Periprosthetic joint infection (PJI) remains one of the most challenging complications of arthroplasty. Optimal antibiotic strategies and the role of multidisciplinary teams (MDT) are not fully defined. We retrospectively analyzed 86 PJI surgical procedures performed between 2017 and 2023 at a tertiary referral center. Clinical data, microbiology, surgical strategy (debridement, antibiotics, and implant retention -DAIR, one-stage, two-stage) and antibiotic regimens were collected. Outcomes were compared across antibiotic classes and treatment teams: orthopaedics alone, orthopaedics with MDT input, and a dedicated MDT (GRIP). Success was defined as infection-free survival without further surgery. Median patient age was 70 years, with high comorbidity and predominance of Gram-positive, monomicrobial infections. Rifampicin-based regimens were associated with higher cure rates than non-anti-biofilm therapy (OR 4.9, 95% CI 1.4–17.8). Flucloxacillin plus rifampicin achieved outcomes comparable to rifampicin–fluoroquinolone combinations. The strongest predictor of success was MDT involvement: in DAIR procedures, cure reached 100% with MDT versus 48% with orthopaedics alone (p = 0.025). Outcomes were similar between teams in one- and two-stage revisions. In this cohort, rifampicin-based therapy improved outcomes in staphylococcal PJI, and flucloxacillin was a valid alternative partner drug. Crucially, MDT management—particularly in DAIR—was associated with superior results. These findings highlight the value of structured multidisciplinary PJI care pathways alongside optimised antibiotic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orthopaedic and Traumatology Department, ULS do Alto Ave, 4835-044 Guimarães, Portugal.
- Orthopaedic and Traumatology Department, ULS Santo António, 4099-001 Porto, Portugal.
- Abel Salazar Institute of Biomedical Sciences, Porto University, 4050-313 Porto, Portugal.
- Porto Bone and Joint Infection Group (GRIP), ULS Santo António, 4099-001 Porto, Portugal.
- Hospital Lusíadas, Av. da Boavista 171, 4050-115 Porto, Portugal.
- Infectious Diseases Department, ULS Santo António, 4099-001 Porto, Portugal.
ORCID-Profile: João Lucas, Daniel Soares, Ricardo Sousa, Miguel Araújo Abreu
Zitieren
APA
Lucas, J., Queirós, J., Soares, D., Carvalho, A., Pereira, F., Santos, C., Sousa, R., & Abreu, M. A. (2025). The Impact of Antibiotic Therapy Options and Multidisciplinary Approach in Prosthetic Joint Infections. Microorganisms, 13(10), 2241. https://doi.org/10.3390/microorganisms13102241
Vancouver
Lucas J, Queirós J, Soares D, Carvalho A, Pereira F, Santos C, et al. The Impact of Antibiotic Therapy Options and Multidisciplinary Approach in Prosthetic Joint Infections. Microorganisms. 2025;13(10):2241. doi:10.3390/microorganisms13102241
BibTeX
@article{Lucas2025,
author = {Lucas, João and Queirós, José and Soares, Daniel and Carvalho, André and Pereira, Filipa and Santos, Cláudia and Sousa, Ricardo and Abreu, Miguel Araújo},
title = {The Impact of Antibiotic Therapy Options and Multidisciplinary Approach in Prosthetic Joint Infections},
journal = {Microorganisms},
year = {2025},
volume = {13},
number = {10},
pages = {2241},
doi = {10.3390/microorganisms13102241}
}
EUVIMED